Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7376
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,519.13
    +448.13 (+0.47%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6840
    -0.0003 (-0.04%)
     

Wall Street Fundamentals Releases New In-Depth Stock Reports on BMY, KMB, PG and SWK

U.S. markets continued to tumble Friday on concerns of slowing global growth. The Dow Jones Industrial Average dropped 318.24 points, down 3.5 percent for the week and its worst weekly loss since 2011. The S&P 500 Index declined 2.09 percent to close at 1,790.29, down 2.6 percent for the week and its worst weekly loss since June 2012. "There's a lack of buyers supporting the market and incremental sellers who are de-risking on the back of the macro developments," said Doug Crofton, head of U.S. cash equity trading at Bank of America Merrill Lynch. "I don't think the market was positioned for the recent events.

Bristol-Myers Squibb Co. (NYSE:BMY - News) shares traded in the range of $50.31 to $55.47 Friday before settling to close at $50.94, a decrease of 5.58 percent. The stock appears to be facing some resistance at the $51.30 and $52.45 levels with some support at $50.28. According to a recent Bloomberg article by Drew Armstrong, the company “wasn’t ready to move ahead with a study of a combination cancer treatment that includes the company’s top prospect.” Shares of Bristol-Myers Squibb have gained approximately 38.0 percent in the past year.

More information on Bristol-Myers Squibb and access to the free equity report can be found at:
www.WallStreetFundamentals.com/BMY

Kimberly Clark Corp. (NYSE:KMB - News) shares traded in the range of $106.75 to $110.42 Friday before settling to close at $107.40, an increase of 1.88 percent. The stock appears to have some support at the $102.39, $94.30 and $93.00 levels. The company reported diluted net income per share was $5.53 in 2013, compared to $4.42 in 2012. Shares of Kimberly Clark have gained approximately 25.0 percent in the past year.

ADVERTISEMENT

More information on Kimberly Clark and access to the free equity report can be found at:
www.WallStreetFundamentals.com/KMB

The Procter & Gamble Company (NYSE:PG - News) shares traded in the range of $79.05 to $81.70 Friday before settling to close at $79.18, an increase of 1.20 percent. The stock appears to be facing some resistance at the $79.31 and $79.88 levels with some support at $78.98. The company reported organic sales in the fourth quarter of 2013 increased 3.0 percent when compared to a year ago. Shares of Procter & Gamble have gained approximately 8.0 percent in the past year.

More information on Procter & Gamble and access to the free equity report can be found at:
www.WallStreetFundamentals.com/PG

Stanley Black & Decker, Inc. (NYSE:SWK - News) shares traded in the range of $77.50 to $82.76 Friday before settling to close at $77.81, a decrease of 3.23 percent. The stock appears to be facing some resistance at the $78.99 and $79.73 levels with some support at $74.37. The company reported a 89.0 percent drop in fourth quarter profit largely due to higher restructuring charges. Shares of Stanley Black & Decker have fallen approximately 3.5 percent year-to-date.

More information on Stanley Black & Decker and access to the free equity report can be found at:
www.WallStreetFundamentals.com/SWK

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com